Full video transcriptClick to expand
Auto-generated transcript of @pinwithben's video. Quoted here for educational fact-check commentary; original creator retains all rights to the video content.
- 0:00I get a lot of question and comments that does anabolic cause hair loss.
- 0:05So let me try to clear it up a little bit.
- 0:08When you have tests in your body, testosterone, which most men should have, that creates a
- 0:14hormone called DHT.
- 0:16What DHT does is it attaches to your hair follicles and it pretty much shrinks it over time and
- 0:20it causes male pattern baldness.
- 0:23So if you have good hair genetics, if it's you have good hair genetics, it's been passed
- 0:28down from your father, grandfather, whatever, your hair follicles are pretty much resistance
- 0:33to DHT.
- 0:34So if you hop on any kind of gear and your test levels raise because of that, it creates DHT,
- 0:40more DHT in your body.
- 0:42But if your hair is already resistant to that, you will most likely not lose your hair even
- 0:47being on gear.
- 0:48But what happens with guys that do have poor hair genetics that are already prone to male
- 0:53pattern baldness.
- 0:55So let's say hop on that increase in DHT is just going to basically fast track their hair
- 1:01loss.
- 1:02So what I'm trying to say is that it's all down to your hair genetics.
- 1:07That's why you see some guys that will hop on and they start losing hair pretty quickly.
- 1:13And then some guys will hop on and they still have a head full hair.
- 1:16It's all based on whether or not you were already pre-prone to male pattern baldness to
- 1:21begin with.
- 1:22It just means that it's just basically going to speed up the process if you were basically
- 1:28prone to that.
- 1:30Hopefully that clears this up.
Do steroids actually cause hair loss, or is it more complicated?
Quick answer
Androgenetic alopecia is mediated by DHT binding to androgen-sensitive follicles, and exogenous testosterone use, particularly at supraphysiologic doses, significantly increases DHT substrate availability via 5-alpha reductase conversion. Genetic predisposition determines follicle sensitivity to androgens, but compound selection, dosing, and duration are additional clinical variables that affect hair loss risk and are absent from this creator's explanation. Patients on TRT at physiologic replacement doses face a meaningfully different risk profile than individuals using anabolic steroids for performance enhancement.
Video review standard
Clinical fact-check snapshot
FormBlends treats social health videos as a starting point, then checks the claim against medical context, source quality, safety limits, and whether licensed provider review belongs in the next step.
Evidence signal
Source-backed review
Regulatory reality
Access rules depend on the compound and patient situation
Safety screen
Viral claims can miss contraindications, dose escalation, medication interactions, and quality-control risks.
This page currently connects to 8 source-backed evidence items through visible references or structured citation data.
PubMed evidence trail
Research sources used to frame this page
For Do steroids actually cause hair loss, or is it more complicated?, FormBlends checks the page topic against primary trials, systematic reviews, guidelines, and current PubMed-indexed literature where available. These citations are context, not medical advice, proof of eligibility, or a claim that every study applies to every patient.
Cardiovascular Safety of Testosterone-Replacement Therapy
TRAVERSE trial anchor for cardiovascular-safety discussions in appropriately diagnosed men.
PubMed
Testosterone therapy in men with androgen deficiency syndromes: an Endocrine Society clinical practice guideline
Guideline anchor for diagnosis, monitoring, contraindications, and appropriate TRT framing.
PubMed
The human peptide GHK-Cu in prevention of oxidative stress and degenerative conditions of aging
Anchor review for copper peptide gene-expression and tissue-repair claims.
PubMed
Effects of glycyl-histidyl-lysine-Cu on wound healing
Search-backed PubMed trail for wound-healing claims where specific topical versus injectable context matters.
PubMed
Provider decision path
Use local research to choose a safer review path
Direct answer
Do steroids actually cause hair loss, or is it more complicated? is best used to compare access, oversight, pricing, pharmacy quality, and patient support before starting care.
Evidence check
Directory pages should connect local intent with provider standards, pharmacy transparency, and practical next steps.
Safety check
Provider quality, pharmacy source, prescribing model, and follow-up support can matter as much as the medication name.
Next step
When you are ready, the get-started flow can collect the details needed for a prescription review instead of leaving you to guess.
Claim path
Keep researching this testosterone and trt video claims cluster
Best for searchers turning TRT social claims into a safer lab-backed provider discussion.
Page-specific review note
What this exact clip is really saying
This FormBlends review is specific to "Do steroids actually cause hair loss, or is it more complicated?" from BenTren. We read the clip as a TRT social video fact-checks claim about Testosterone, then separate the useful signal from what a short social video cannot prove. The page-specific claim focus is: Androgenetic alopecia is mediated by DHT binding to androgen-sensitive follicles, and exogenous testosterone use, particularly at supraphysiologic doses, significantly increases DHT substrate availability via 5-alpha reductase conversion.
The reason this review is not generic is the source wording and the canonical claim label "trt thinking of blasting but worried about going bald let s clea." In this clip, the useful excerpt is: "I get a lot of question and comments that does anabolic cause hair loss." That wording changes the review because it points to Testosterone evidence, safety, and patient-fit context, not a one-size-fits-all protocol.
The source trail for this page is checked against Cardiovascular Safety of Testosterone-Replacement Therapy (2023), Testosterone therapy in men with androgen deficiency syndromes: an Endocrine Society clinical practice guideline (2010), and Functional testosterone deficiency in aging men: Clinical impact, diagnostic pathways, and treatment strategies (2026), plus the creator's own wording. Testosterone decisions still need an eligibility review, medication-interaction screen, access check, and quality-control review before anyone treats a social clip as medical advice.
Claim verdict
The useful answer behind this video
This page is built to answer the specific claim behind the clip, then separate what is useful from what still needs clinical context. That makes the URL more than a repost: it gives Google, readers, and AI retrieval systems a concise verdict with source and safety boundaries.
Claim being checked
Androgenetic alopecia is mediated by DHT binding to androgen-sensitive follicles, and exogenous testosterone use, particularly at supraphysiologic doses, significantly increases DHT substrate availability via 5-alpha reductase conversion.
FormBlends verdict
Testosterone evidence, safety, and patient-fit context
Evidence strength
Source-backed review with clinical or regulatory citations.
Patient-safe next step
Compare the claim with FormBlends safety guidance and a licensed-provider review before acting.
What to do with this video
Use the clip as a claim to verify, not a treatment plan
What it helps with
- Androgenetic alopecia is mediated by DHT binding to androgen-sensitive follicles, and exogenous testosterone use, particularly at supraphysiologic doses, significantly increases DHT substrate availability via 5-alpha reductase conversion. Genetic predisposition determines follicle sensitivity to androgens, but compound selection, dosing, and duration are additional clinical variables that affect hair loss risk and are absent from this creator's explanation. Patients on TRT at physiologic replacement doses face a meaningfully different risk profile than individuals using anabolic steroids for performance enhancement.
- DHT-driven follicle miniaturization is the established mechanism of androgenetic alopecia, confirmed in Randall et al. (1992, Journal of Endocrinology), and the creator explains this correctly.
- Not all anabolic compounds carry equal hair loss risk. DHT derivatives like stanozolol and Masteron bind follicle receptors directly, while nandrolone converts to a weaker androgen with lower follicle impact.
What it may miss
- It may not cover eligibility, contraindications, medication interactions, lab history, or dose escalation.
- Compound access, legal status, and product quality still need a separate safety check.
- Social video captions rarely show the full evidence base behind a claim.
Best next step
Compare the claim against a FormBlends guide, safety page, and licensed-provider review before acting.
Start provider reviewWhat You'll Learn
- DHT-driven follicle miniaturization is the established mechanism of androgenetic alopecia, confirmed in Randall et al. (1992, Journal of Endocrinology), and the creator explains this correctly.
- Not all anabolic compounds carry equal hair loss risk. DHT derivatives like stanozolol and Masteron bind follicle receptors directly, while nandrolone converts to a weaker androgen with lower follicle impact.
- Supraphysiologic testosterone doses, typical of blast protocols, produce significantly more DHT than physiologic TRT doses, making direct comparison of their hair risks misleading.
- A family history of good hair does not guarantee immunity from androgen-driven hair loss at very high androgen exposures. The genetics are probabilistic, not deterministic.
- Finasteride blocks 5-alpha reductase and reduces DHT conversion, but it requires a prescription, carries its own side effect risks, and does not mitigate the effects of DHT-derived compounds that don't require conversion.
- Hair follicle miniaturization from chronic androgen exposure can be permanent once complete, meaning accelerated loss is not simply a timing issue but a potential long-term outcome.
- Clinical evidence, including Kinter and Schmidt (2021, StatPearls), confirms that both genetic susceptibility and androgen exposure are required for androgenetic alopecia, which supports the creator's core argument while not excusing the oversimplification.
Our take · Written by FormBlends editorial team · Reviewed by FormBlends Medical Team · This is not a transcript. It is our independent review of the video above.
What did @pinwithben actually say?
The core claim is straightforward: anabolic steroids raise testosterone, which converts to DHT, and DHT shrinks hair follicles. But whether you actually lose hair depends entirely on your genetics. "If your hair is already resistant to that, you will most likely not lose your hair even being on gear." For guys who are already prone to male pattern baldness, steroids "just basically fast track their hair loss." He's framing this as a myth-bust, arguing it's not steroids causing hair loss, it's your genetic lottery ticket.
To his credit, he's not selling anything here and he's not telling people to blast without consequence. The framing is relatively honest about risk. But the genetics-only explanation leaves out some important mechanics that matter a lot for real-world outcomes.
Does the science back this up?
Mostly, yes. The DHT pathway he describes is well-established. Androgenetic alopecia (male pattern baldness) is driven by DHT binding to androgen receptors in genetically sensitive follicles, causing progressive miniaturization. Randall et al. (1992, Journal of Endocrinology) were among the first to clearly map this receptor-driven process. The genetic component is real and significant.
The 5-alpha reductase enzyme converts testosterone to DHT, and supraphysiologic testosterone doses, which is what "blasting" means, dramatically increase the substrate available for that conversion. A 2021 review by Kinter and Schmidt in StatPearls confirms that androgenetic alopecia requires both genetic predisposition and androgen exposure. So the genetics story is not wrong. It's just incomplete in ways that matter when someone is deciding whether to run a cycle.
One thing the science is less settled on: the claim that someone with "good hair genetics" will "most likely not lose hair" on gear. That's plausible but not guaranteed. High enough androgen load can push borderline cases over the edge, and some steroids, particularly DHT derivatives like trenbolone or Masteron, are more aggressive on follicles than testosterone alone.
What did they get wrong (or right)?
He got the basic mechanism right. DHT, follicle sensitivity, genetic predisposition, that's the actual biology. Give credit where it's due.
What he glossed over is that not all anabolics are equal in terms of hair impact. He talks about "gear" as a monolithic category, but that's not how it works. Nandrolone (Deca) converts to a weaker androgen, dihydronandrolone, and is considered relatively hair-friendly. By contrast, DHT-derived compounds like stanozolol or Masteron don't need to convert at all because they're already potent androgens that bind directly to follicle receptors. Rassman and Bernstein (2017, International Journal of Trichology) have written about how the compound choice, not just the presence of androgens, affects hair outcomes.
He also presents genetics as binary: you're either prone or you're not. In reality, androgenetic alopecia exists on a spectrum. Someone who might have lost hair at 55 could find themselves losing it at 27 on a blast cycle. That's not splitting hairs, it's a meaningful distinction for a 23-year-old watching this video.
What should you actually know?
If you're considering exogenous testosterone or anabolics and you care about your hair, here's what the evidence actually supports:
- Your family history matters, but it's not a guarantee either way. Having a full-haired grandfather doesn't make you immune to DHT-driven follicle damage at supraphysiologic androgen levels.
- The specific compound matters. Not all steroids carry the same hair risk. DHT-derived compounds carry higher risk than testosterone-based ones, which carry higher risk than nandrolone-based ones.
- Dose and duration matter. A physiologic TRT dose (bringing someone from clinically low testosterone to normal range) carries far less hair risk than a blast protocol designed to push testosterone several times above the normal range.
- Finasteride, a 5-alpha reductase inhibitor, blocks DHT conversion and is used to mitigate hair loss in this context, but it comes with its own side effect profile and is a prescription medication. It's not a free pass.
- Hair loss from androgen exposure can be permanent if follicles are fully miniaturized. Slowing down a process is not the same as stopping it.
The video is useful as a starting point, but anyone making decisions about anabolics based on a 90-second TikTok is working with an incomplete picture.
Interested in GLP-1 or peptide therapy?
Get matched with licensed-provider review to help decide if it is right for you.
About the Creator
BenTren · TikTok creator
5.8K views on this video
Thinking of blasting but worried about going bald? Let’s clear up the steroid hair loss myth real quick 🧢💉 #Steroids #HairLoss #DHT #TRT #Testosterone #Bodybuilding #NattyOrNot #GearTalk #GymTikTok #Balding #Hairline #FitnessMyths #JuiceTalk #Anabolic #MenHealth #TestTalk #fyp
Frequently asked questions
Quick answers based on this video and our medical team review.
What does the video say about dht-driven follicle miniaturization?
DHT-driven follicle miniaturization is the established mechanism of androgenetic alopecia, confirmed in Randall et al. (1992, Journal of Endocrinology), and the creator explains this correctly.
What does the video say about not all anabolic compounds carry equal hair loss risk. dht?
Not all anabolic compounds carry equal hair loss risk. DHT derivatives like stanozolol and Masteron bind follicle receptors directly, while nandrolone converts to a weaker androgen with lower follicle impact.
What does the video say about supraphysiologic testosterone doses, typical of blast protocols, produce significantly more?
Supraphysiologic testosterone doses, typical of blast protocols, produce significantly more DHT than physiologic TRT doses, making direct comparison of their hair risks misleading.
What does the video say about a family history of good hair does not guarantee immunity?
A family history of good hair does not guarantee immunity from androgen-driven hair loss at very high androgen exposures. The genetics are probabilistic, not deterministic.
What does the video say about finasteride blocks 5-alpha reductase?
Finasteride blocks 5-alpha reductase and reduces DHT conversion, but it requires a prescription, carries its own side effect risks, and does not mitigate the effects of DHT-derived compounds that don't require conversion.
What does the video say about hair follicle miniaturization from chronic?
Hair follicle miniaturization from chronic androgen exposure can be permanent once complete, meaning accelerated loss is not simply a timing issue but a potential long-term outcome.
Sources & references
Citations extracted from our medical team's review. Click any citation to search PubMed.
Not medical advice. This video was made by BenTren, not by FormBlends. Our write-up above is an editorial review, not a medical recommendation. Talk to your doctor before making any decisions about medications or treatments.